The role of nitric oxide in δ-aminolevulinic acid (ALA)-induced photosensitivity of cancerous cells

Biochemical and Biophysical Research Communications

Volumn 353, Issue 3, 2007, Pages 541-546

  Yamamoto, Fuki ^a   Ohgari, Yoshiko ^a   Yamaki, Nao ^a   Kitajima, Sakihito ^a   Shimokawa, Osamu ^b   Matsui, Hirofumi ^b   Taketani, Shigeru ^a  

^a KYOTO INSTITUTE OF TECHNOLOGY   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Aminolevulinic acid; NO; PDT; Photo damage; Protoporphyrin

Indexed keywords

AMINOLEVULINIC ACID; COMPLEMENTARY DNA; FERROCHELATASE; GAMMA INTERFERON; HEME; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MITOCHONDRIAL ENZYME; N(G) METHYLARGININE; N(G) METHYLARGININE ACETATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PROTOPORPHYRIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; ROTENONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOACCUMULATION; CANCER CELL; CELL DEATH; CELL STRAIN HEK293; CONTROLLED STUDY; GENETIC TRANSFECTION; HEME SYNTHESIS; HUMAN; LIGHT EXPOSURE; MACROPHAGE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINOLEVULINIC ACID; ANIMALS; CELL LINE; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; FERROCHELATASE; HUMANS; INTERFERON TYPE II; KIDNEY; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; OMEGA-N-METHYLARGININE; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS;

EID: 33845972212     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.12.007     Document Type: Article

References (34)

1. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., and Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90 (1998) 889-905
2. Sibata M.N., Tedesco A.C., and Marchetti J.M. Photophysicals and photochemicals studies of zinc(II) phthalocyanine in long time circulation micelles for photodynamic therapy use. Eur. J. Pharm. Sci. 23 (2004) 131-138
3. Chen Y., Zheng X., Dobhal M.P., Gryshuk A., Morgan J., Dougherty T.J., Oseroff A., and Pandey R.K. Methyl pyropheophorbide-α analogues: potential fluorescent probes for the peripheral-type benzodiazepine receptor. Effect of central metal in photosensitizing efficacy. J. Med. Chem. 48 (2005) 3692-3695
4. Fischer F., Dickson E.F., Kennedy J.C., and Pottier R.H. An affordable, portable fluorescence imaging device for skin lesion detection using a dual wavelength approach for image contrast enhancement and aminolaevulinic acid-induced protoporphyrin IX. Part II. In vivo testing. Lasers Med. Sci. 16 (2001) 207-212
5. Peng Q., Berg K., Moan J., Kongshaug M., and Nesland J.M. 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem. Photobiol. 65 (1997) 235-251
6. Peng Q., Warloe T., Berg K., Moan J., Kongshaug M., Giercksky K.E., and Nesland J.M. 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges. Cancer 79 (1997) 2282-2308
7. Ohgari Y., Nakayasu Y., Kitajima S., Sawamoto M., Mori H., Shimokawa O., Matsui H., and Taketani S. Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. Biochem. Pharmacol. 71 (2005) 42-49
8. Dailey H.A., and Smith A. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem. J. 223 (1983) 441-445
9. Nathan C., and Xie Q.W. Nitric oxide synthases: roles, tolls, and controls. Cell 78 (1994) 915-918
10. Alderton W.K., Cooper C.E., and Knowles R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357 Pt 3 (2001) 593-615
11. Lala P.K., and Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol. 2 (2001) 149-156
12. Brown G.C., and Borutaite V. Inhibition of mitochondrial respiratory complex I by nitric oxide, peroxynitrite and S-nitrosothiols. Biochim. Biophys. Acta 1658 (2004) 44-49
13. Payne C.M., Bernstein C., Bernstein H., Gerner E.W., and Garewal H. Reactive nitrogen species in colon carcinogenesis. Antioxid. Redox Signal. 1 (1999) 449-467
14. Cooper C.E. Nitric oxide and iron proteins. Biochim. Biophys. Acta 1411 (1999) 290-309
15. Furukawa T., Kohno H., Tokunaga R., and Taketani S. Nitric oxide-mediated inactivation of mammalian ferrochelatase in vivo and in vitro: possible involvement of the iron-sulphur cluster of the enzyme. Biochem. J. 310 (1995) 533-538
16. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
17. Taketani S., Tanaka A., and Tokunaga R. Reconstitution of heme-synthesizing activity from ferric ion and porphyrins, and the effect of lead on the activity. Arch. Biochem. Biophys. 242 (1985) 291-296
18. Taketani S., Tanaka-Yoshioka A., Masaki R., Tashiro Y., and Tokunaga R. Association of ferrochelatase with Complex I in bovine heart mitochondria. Biochim. Biophys. Acta 883 (1986) 277-283
19. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
20. Suzuki N., Kojima H., Urano Y., Kikuchi K., Hirata Y., and Nagano T. Orthogonality of calcium concentration and ability of 4,5-diaminofluorescein to detect NO. J. Biol. Chem. 277 (2002) 47-49
21. Schoenfeld N., Epstein O., Lahav M., Mamet R., Shaklai M., and Atsmon A. The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders. Cancer Lett. 43 (1988) 43-48
22. Kondo M., Hirota N., Takaoka T., and Kajiwara M. Heme-biosynthetic enzyme activities and porphyrin accumulation in normal liver and hepatoma cell lines of rat. Cell. Biol. Toxicol. 9 (1993) 95-105
23. Brown G.C. Regulation of mitochondrial respiration by nitric oxide inhibition of cytochrome c oxidase. Biochim. Biophys. Acta 1504 (2001) 46-57
24. Kim Y.M., Bergonia H.A., Muller C., Pitt B.R., Watkins W.D., and Lancaster Jr. J.R. Loss and degradation of enzyme-bound heme induced by cellular nitric oxide synthesis. J. Biol. Chem. 270 (1995) 5710-5713
25. Broch J.H. Iron Infection, Immunity, Inflammation and Neoplasia. In: Brock J.H., Halliday J.W., Pippard M.S., and Powell L.W. (Eds). Iron Metabolism in Health and Diseases (1994), Saunders, London 353-389
26. Taketani S., Adachi Y., and Nakahashi Y. Regulation of the expression of human ferrochelatase by intracellular iron levels. Eur. J. Biochem. 267 (2000) 4685-4692
27. Pearce L.L., Kanai A.J., Epperly M.W., and Peterson J. Nitrosative stress results in irreversible inhibition of purified mitochondrial complexes I and III without modification of cofactors. Nitric Oxide. 13 (2005) 254-263
28. Dailey H.A., Finnegan M.G., and Johnson M.S. Human ferrochelatase is an iron-sulfur protein. Biochemistry 33 (1994) 403-407
29. Ambs S., Merriam W.G., Bennett W.P., Felley-Bosco E., Ogunfusika M.O., Oser S.M., Klein S., Shields P.G., Billiar T.R., and Harris C.C. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression. Cancer Res. 58 (1998) 334-341
30. Korbelik M., Parkins C.S., Shibuya H., Cecic I., Stratford M.R., and Chaplin D.J. Nitric oxide production by tumour tissue: impact on the response to photodynamic therapy. Br. J. Cancer 82 (2000) 1835-1843
31. Niziolek M., Korytowski W., and Girott A.W. Nitric oxide-induced resistance to lethal photo oxidative damage in a breast tumor cell line. Free Radic. Biol. Med. 40 (2006) 1323-1331
32. Gomes E.R., Almeida R.D., Carvalho A.P., and Duarte C.B. Nitric oxide modulates tumor cell death induced by photodynamic therapy through a cGMP-dependent mechanism. Photochem. Photobiol. 76 (2002) 423-430
33. Yerushalmi H.F., Besselsen D.G., Ignatenko N.A., Blohm-Mangone K.A., Padilla-Torres J.L., Stringer D.E., Cui H., Holubec H., Payne C.M., and Gerner E.W. The role of NO synthases in arginine-dependent small intestinal and colonic carcinogenesis. Mol. Carcinog. 45 (2006) 93-105
34. Jadeski L.C., Hum K.O., Chakraborty C., and Lala P.K. Nitric oxide promotes murine mammary tumour growth and metastasis by stimulating tumour cell migration, invasiveness and angiogenesis. Int. J. Cancer. 86 (2000) 30-39